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ABSTRACT 
Drug nanocrystals are the latest, broadly introduced nanoparticulate carrier to the 
pharmaceutical market from the year 2000 onwards. The special features of nanocrystals for 
the delivery of poorly soluble drugs are briefly reviewed (saturation solubility, dissolution 
velocity, adhesiveness). The industrially relevant bottom up (precipitation) and top down 
production technologies (pearl milling, high pressure homogenization, combination 
technologies) are presented. As nanotoxicological aspects, the effect of size, degradability 
versus biopersistency and intracellular uptake are discussed, classifying the nanocrystals in 
the low/non-risk group. Intracellular uptake plays a minor or no role for dermal and oral 
nanocrystals, but it plays a key role for intravenously injected nanocrystals (e.g. nevirapine, 
paclitaxel, itraconazole). Uptake by the macrophages of the mononuclear phagocytic system 
(MPS, liver spleen) can modify/optimize blood profiles via prolonged release from the MPS 
(itraconazole), but also target toxicity by too high organ concentrations and thus cause 
nanotoxicity. The balance in the competitive intracellular uptake by MPS and the target cells 
(e.g. blood–brain barrier) decides about therapeutic efficiency. The concept of “differential 
protein adsorption” to modulate this balance is shown for its applicability to nanocrystals for 
intracellular delivery to the cells of the blood–brain barrier (atovaquone). 
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